Massive congrats to Benjamin Goldstein and the team on completion of this incredibly innovative trial on nitrous oxide in bipolar depression CAMH CAMH Research Sunnybrook Health Sciences Centre UofTPsychiatry!!! onlinelibrary.wiley.com/doi/10.1111/bd…

Read our most recent newsletter: 2022 in Review: FDA Approvals in Psychiatry. psychopharmacologyinstitute.com/publication/ja… #psychopharm #psychiatry #psychtwitter #MedTwitter

About 10-20% of patients with bipolar disorder have DSM-based ADHD. To treat this comorbidity, stabilize mood first. Alpha-agonists and the modafinils are good options to start with, while the stimulants may carry risks in BD #mentalhealth thecarlatreport.com/articles/3573-…

Let’s look at #TreatmentResistant #Depression from a different angle 🕵️‍♀️ 🔎 Perhaps we could use a gauge. Thanks to European Psychiatry for publishing our work.

Estrogen protects against schizophrenia, delaying its onset in women, but does prescription estrogen augment antipsychotics in women with #Schizophrenia? Yes, concludes new meta-analysis. pubmed.ncbi.nlm.nih.gov/36585771/

#eNeuro | A New Tool for Quantifying Mouse Facial Expressions eneuro.org/content/10/2/E…

The best place ever to work in…

Simon 🏕️ "The concept of a diagnostic hierarchy implies that certain diagnoses should not be made when others are present. This approach contrasts with the DSM-based approach of making multiple diagnoses at the same time, which leads to the problem of comorbidity." academic.oup.com/book/25301/cha…

If you are interested in progress in research on depression by using mouse models, then this webinar is for you - Introducing a depression-like syndrome for translational neuropsychiatry, based on the review nature.com/articles/s4138… , registration link 👇

Congratulations to Danica Johnson Mood Disorders Psychopharmacology Unit UofTPsychiatry: An update on potential pharmacotherapies for cognitive impairment in bipolar disorder FYI Danica is studying the effect of #ketamine and #psilocybin on cognitive function so more to come! tandfonline.com/doi/abs/10.108…

Two open-label extension studies show sustained improvement of negative symptoms of schizophrenia with roluperidone, a drug with no dopaminergic binding affinities but antagonist properties for 5-HT2A, sigma2, α1A- and α1B-adrenergic receptors sciencedirect.com/science/articl…

Lateral septum adenosine A2A receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula ift.tt/Tuf7vPD

Are you an experienced researcher eager to spearhead our efforts in collecting, harmonizing and analyzing existing large-scale datasets of patients with mental disorders as part of the new German Centre for Mental Health? Please apply: lnkd.in/ebBy6Ksx

Join the next PsychX talk on Monday where Eduard Vieta gives a talk on recent advances in bipolar disorder. The ECNP-PsychX talks are free for everyone around the world to attend. You just need to be interested.

Be sure to join the upcoming free of charge ECNP-PsychX talk, where Eiko Fried will walk us through the approach to mental health problems as systems and the promises it holds, followed by a Q&A session. Mark your calendars for Monday, April 8, at 4:30 PM (CET).

Final reminder 🚨 Join Eiko Fried's online talk today at 16.30 CEST. Find details on how to join here: ecnp.eu/psychx-talks #MoodDisorders #MentalHealthResearch #depression

Thrilled to announce our latest publication on the regulation of mitochondrial dysfunction by estrogens and estrogen receptors in #Alzheimer’s disease. onlinelibrary.wiley.com/doi/10.1111/bc… Many thanks to Shokouh Arjmand and grateful for the collaboration with Albert Gjedde and Gregers Wegener.

SCNP Annual Congress kick off. Workshop in drug discovery. From Research to IP. scnp.org/fileadmin/SCNP… Göteborgs universitet / University of Gothenburg Acta Neuropsychiatrica Henrik Sjölander #drugdiscovery #mentalhealth #SCNP #SCNP2024

SCNP 62nd Annual Congress live! Ingrid Melle speaks about 'Treatment resistance in psychotic disorders' SCNP Universitetet i Oslo NORMENT Ingrid Melle Göteborgs universitet / University of Gothenburg #SCNP2024 #SCNP #schizophrenia